Valuation : Acarix AB

Market Cap 302M 31.51M 27.15M 25.46M 23.24M 43.78M 3.01B 43.92M 118M 1.52B 118M 116M 5.04B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 302M 31.51M 27.15M 25.46M 23.24M 43.78M 3.01B 43.92M 118M 1.52B 118M 116M 5.04B EV / Sales 2026 *
21.6x
EV / Sales 2027 * 9.44x
Free-Float
79.69%
Yield 2026 *
-
Yield 2027 * -
1 day+2.13%
1 week+5.88%
Current month-7.10%
1 month-2.70%
3 months-10.00%
6 months-17.71%
Current year-16.28%
1 week 0.01
Extreme 0.0135
0.03
1 month 0.01
Extreme 0.0135
0.03
Current year 0.01
Extreme 0.0135
0.04
1 year 0.01
Extreme 0.0135
0.04
3 years 0.01
Extreme 0.0112
0.05
5 years 0.01
Extreme 0.0112
0.14
10 years 0.01
Extreme 0.0112
2.37
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%+5.88% - - 31.29M
+1.24%+2.71%+29.01%-28.13% 17.96B
-0.71%-2.30%-25.51%+101.29% 1.66B
-4.18%+0.81%-46.93%-80.76% 1.05B
+0.61%-3.00%-24.26%+22.67% 959M
+0.08%-0.05%+61.29%-5.52% 779M
-3.02%-4.58%-35.97%-46.09% 693M
+0.18%-2.01%-42.83%-48.50% 565M
+0.67%+1.77%-37.71%-35.71% 461M
-4.37%+0.66%+71.73%+47.87% 459M
Average -0.72%+3.09%-5.69%-8.10% 2.73B
Weighted average by Cap. +0.44%+1.51%+17.09%-18.63%

Financials

2026 *2027 *
Net sales 14M 1.46M 1.26M 1.18M 1.08M 2.03M 140M 2.04M 5.46M 70.46M 5.48M 5.36M 234M 32M 3.34M 2.88M 2.7M 2.46M 4.64M 319M 4.65M 12.49M 161M 12.53M 12.26M 534M
Net income -30.8M -3.21M -2.77M -2.6M -2.37M -4.46M -307M -4.48M -12.02M -155M -12.06M -11.8M -514M -15.3M -1.6M -1.38M -1.29M -1.18M -2.22M -153M -2.22M -5.97M -77.01M -5.99M -5.86M -255M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change
28/08/26 0.0144 +2.13%
27/08/26 €0.0141 -52.68%
26/08/26 €0.0298 +120.74%
25/08/26 €0.0135 -0.74%
24/08/26 €0.0136 0.00%

Quarterly revenue - Rate of surprise